Specifically, established mediators of cardiac hypertrophy such as atrial natriuretic peptide, brain natriuretic peptide and angiotensin-II have shown to increase the ratio of non-myocyte to myocytes (46, 47). The gene discussed is NPPA; the disease is cardiac hypertrophy.